Details About Generic Salt ::  Isoethar

Main Medicine Class:: Bronchodilator,Sympathomimetic   

(EYE-so-ETH-uh-reen)
Isoetharine Hydrocholoride
Isoetharine HCl
Class: Bronchodilator/Sympathomimetic

 

Drugs Class ::

 Action Produces bronchodilation by relaxing bronchial smooth muscle through beta-2 adrenergic receptor stimulation.

Indications for Drugs ::

 Indications Relief of bronchial asthma and reversible bronchospasm associated with bronchitis and emphysema.

Drug Dose ::

 Route/Dosage

Individualize dosage.

HAND NEBULIZER

ADULTS & CHILDREN ³ 12 YR: Inhalation 3 to 7 inhalations undiluted q 4 hr prn.

INTERMITTENT POSITIVE PRESSURE BREATHING ADMINISTRATION

ADULTS & CHILDREN ³ 12 YR: Inhalation 0.5 ml of 1% solution diluted 1:3 with saline. Inspiratory flow rate of 15 L/min at cycling pressure of 15 cm H2O, but can be adjusted according to patient needs.

OXYGEN AEROSOLIZATION

ADULTS & CHILDREN ³ 12 YR: Inhalation 0.5 ml of 1% solution diluted 1:3 with saline. Adjust oxygen flow to 4 to 6 L/min over 15 to 20 min.

Contraindication ::

 Contraindications Hypersensitivity to any components; cardiac arrhythmias associated with tachycardia; tachycardia or heartblock caused by digitalis intoxication; narrow-angle glaucoma.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy in children £ 12 yr not established. Elderly patients: Lower doses may be required. Special risk patients: Dosage needs to be carefully adjusted in patients with hyperthyroidism, hypertension, acute coronary disease and patients sensitive to sympathomimetic amine to prevent tachycardia, palpitations, and headache. Cardiovascular effects: Toxic symptoms in patients with cardiovascular disorders may occur. CNS effects: CNS stimulation may occur; use drug with caution in patients with history of seizures or hyperthyroidism. Diabetes mellitus: Dosage adjustment of insulin or oral hypoglycemic agent may be required. Excessive use: Paradoxical bronchospasm and cardiac arrest have been associated with excessive inhalant use. Sulfite sensitivity: Some products contain sulfites that may cause allergic-type reactions including anaphylactic symptoms. Tolerance: If previously effective dose fails to provide relief, therapy may need to be reassessed. Combined therapy: Do not use ³ 2 beta-adrenergic aerosol bronchodilators simultaneously because of potential of additive effects. Do not use as a substitute for oral or inhaled corticosteroids.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Palpitations; tachycardia; elevated BP. CNS: Tremor; vertigo; anxiety; nervousness; weakness; restlessness; hyperactivity; headache; insomnia. GI: Nausea; vomiting.

Drug Mode of Action ::  

 Action Produces bronchodilation by relaxing bronchial smooth muscle through beta-2 adrenergic receptor stimulation.

Drug Interactions ::

 Interactions

Epinephrine, other sympathomimetics: May cause excessive tachycardia.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Monitor respiratory and cardiac status, including BP and pulse, before and after therapy.
  • Observe for paresthesias and coldness of extremities and decreased peripheral blood flow.
  • Notify physician of failure to respond to usual dosage and of dizziness and chest pain.
  • Monitor respiratory functions (eg, vital capacity, forced expiratory volume, arterial blood gases).
  • Observe for therapeutic response as demonstrated by adequate breathing.
OVERDOSAGE: SIGNS & SYMPTOMS
  Hypertension, tachycardia, palpitations, tremor, nausea, headache, anxiety, restlessness, insomnia, weakness, dizziness, excitation

Drug Storage/Management ::

 Administration/Storage

  • Dilute 1% nebulizer/intermittent positive pressure breathing solution 1:3 with normal saline.
  • Nebulizer use: Find location where patient can sit comfortably for 10 to 15 min. Do not mix different types of medications without permission from doctor or pharmacist. Instruct patient to take slow, deep breaths and, if possible, to hold breath for 10 seconds before slowly exhaling. Continue until medication chamber is empty.
  • Administer inhaled bronchodilator before giving other inhaled agents (eg, cromolyn, steroids).
  • Do not use if solution is discolored or contains precipitate.
  • Store at room temperature and protect from light.

Drug Notes ::

 Patient/Family Education

  • Instruct patient on proper use of inhaler. Explain value of using spacing device.
  • Instruct patient on proper method of determining when metered dose inhaler is empty and when it needs to be replaced.
  • Advise patient to use bronchodilator before taking other inhaled agents (eg, cromolyn, steroids).
  • Advise patient not to exceed or adjust recommended dosage and not to change brands without consulting physician.
  • Caution patient to avoid spraying aerosol in eyes.
  • Encourage patient to increase fluid intake, which helps in liquefying secretions.
  • Instruct patient to notify physician if signs of paradoxical airway resistance (eg, sudden increase in shortness of breath) occur.
  • Advise patient to notify physician of failure to respond to usual dosage and of dizziness and chest pain.
  • Advise patient to avoid smoking, being in smoke-filled rooms, and having contact with people who have respiratory infections.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.